Drugs / PIK-PD-1 cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02632006 | Sep 2015 → Mar 2017 | hepatocellular carcinoma | Second Military Medical University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PIK-PD-1 cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02632006 ↗ |
| Modality | Cell therapy | “PIK-PD-1 cell suspension” NCT02632006 ↗ |
| Route | Intravenous | “IV (in the vein) for each infusion” NCT02632006 ↗ |